ABCA1 mRNA expression significantly increased in the atorvastatin-medicated CAD group compared to the control group (p = 0.001) and the non-medicated CAD group with atorvastatin (p = 0.011). This evidence concerns the gene ABCA1 and coronary artery disorder.